Alternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long‐Term Cardiovascular Mortality
Background Complement activation may promote atherosclerosis. Yet, data on the to which extent complement, and more specifically the alternative complement pathway, is activated in patients with carotid atherosclerosis and related to adverse outcome in these patients, are scarce. Methods and Results...
Saved in:
Main Authors: | Mieke C. Louwe, Chrysostomi Gialeli, Annika E. Michelsen, Sverre Holm, Andreas Edsfeldt, Karolina Skagen, Tove Lekva, Maria Belland Olsen, Vigdis Bjerkeli, Therese Schjørlien, Kristine Stø, Xiang Yi Kong, Tuva B. Dahl, Per H. Nilsson, Peter Libby, Pål Aukrust, Tom Eirik Mollnes, Thor Ueland, Mona Skjelland, Isabel Gonçalves, Bente Halvorsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.038316 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seventy Years Later: Systemic and Local Properdin in Atherosclerosis
by: Jean F. Regal, et al.
Published: (2025-02-01) -
Characterization of the bispecific VHH antibody tarperprumig (ALXN1820) specific for properdin and designed for low-volume administration
by: Paul Tamburini, et al.
Published: (2024-12-01) -
On certain quasi-complemented and complemented Banach algebras
by: Pak-Ken Wong
Published: (1978-01-01) -
Acidosis activates complement system in vitro
by: Michael Emeis, et al.
Published: (1998-01-01) -
Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen
by: Michael L. McCaleb, et al.
Published: (2025-03-01)